Artificial intelligence (AI) is revolutionizing drug development by accelerating target identification, molecule design, and clinical trials, while also reducing costs. As AI-based drugs proceed rapidly in progress, doctors could reportedly prescribe these within years. The next phase, multiomics, tackles data complexity by blending information from genomes, proteomes, etc. This could speed up development even more and identify links missed by human researchers. However, AI systems currently lack accuracy due to continual biological discoveries and the complexities of biological systems.
IXON VPN Vulnerabilities Let Attackers Gain Access to Windows & Linux Systems
A security assessment by Shelltrail revealed three critical vulnerabilities in the IXON VPN client, allowing privilege escalation on Windows and Linux. Identified as CVE-2025-ZZZ-01, CVE-2025-ZZZ-02,
%20CISO%E2%80%99s%20Core%20Focus.webp?w=0&resize=0,0&ssl=1 "Identity and Access Management (IAM)")